Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy

NCT06266546 is registered in ClinicalTrials.gov with Youssef Yammine as lead sponsor.

NCT NCT06266546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06266546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy
Lead sponsor
Youssef Yammine
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 1, 2024
Completion date
March 1, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endobronchial mass, hemorrhage lung